ICAAC 45th

Drupal spam blocked by CleanTalk.
Title Content type
Antifungal Activity of BAL4815, a Novel Azole Against Dermatophytes and Emerging Non-Dermatophyte Fungi Including Zygomycetes (click for details)
In vitro activity of the new azole BAL4815 against clinical dermatophyte isolates (click for details)
In Vitro Activity of the New Azole BAL4815 against Clinical Candida Isolates Comprising Resistant C. albicans and Less Susceptible Candida spp (click for details)
Efficacy, Safety, and Tolerability of three Different Dosing Regimens of BAL8557 Vs. Fluconazole in a Double-Blind, Randomized, Multicenter Trial for the Treatment of Esophageal Candidiasis in Immunocompromised Adults (click for details)
In vivo Efficacy of the triazole BAL8557 (BAL) Compared to Voriconazole (VOR), Itraconazole (ITC) and Caspofungin (CAS) By a New qPCR and Quantitative Culture in a Neutropenic Murine Model of Aspergillus flavus (click for details)
Dose Response Curves and Dose Fractionation Studies with BAL8557 in a Murine Model of Disseminated Candidiasis (click for details)
Decision Making in Treatment of Invasive Aspergillosis at an Academic Medical Center (click for details)
Extended Loss of Susceptibility to Azoles in Aspergillus fumigatus: Analysis of 596 Strains (click for details)
Caspofungin Versus Liposomal Amphotericin B for Empirical Therapy in Children with Persistently Febrile Neutropenia (click for details)
A Single Amino Acid Substitution in TAC1, a Transcription Factor Responsible for the Regulation of CDR1 and CDR2 in Candida albicans, can Mediate Azole Resistance (click for details)


Subscribe to ICAAC 45th